Alliance for Biopharmaceutical Competitiveness and Innovation

Biopharmaceutical industry

Based in DC

🤖

AI Overview

With $6.0M in lobbying spend across 28 quarterly filings, Alliance for Biopharmaceutical Competitiveness and Innovation is one of the biggest lobbying spenders in Washington. Their lobbying covers 1 issue area. Active from 2018 to 2025.

$6.0M

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$300K
2019	$510K
2020	$350K
2021	$440K
2022	$920K
2023	$1.0M
2024	$1.5M
2025	$970K

Issues Lobbied

Taxation

Lobbying Firms

The Washington Tax & Public Policy Group

Lobbyists

Gregory Nickerson Jan Fowler Brian Diffell Kelli Briggs Zachary Price James Pedrotti

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation

Issues related to corporate and international tax reform including issues related to IRC sections 904(d), 951A, 250, 59A, 163(j), 954(c)(6), 172, 174, and 965. Issues related to Puerto Rico.

Issues related to corporate and international tax reform including issues related to IRC sections 904(d), 951A, 250, 59A, 163(j), 954(c)(6), 172, 174, and 965. Issues related to Puerto Rico incentives and excise taxes.

Issues related to corporate and international tax including issues related to IRC sections 904(d), 951A, 250, 59A, 163(j), 954(c)(6), 172, 174, and 965. Issues related to Puerto Rico incentives and excise taxes.

Issues related to corporate and international tax including issues related to IRC sections 904(d), 951A, 250, 59A, 163(j), 954(c)(6), 172, and 174. Issues related to Puerto Rico incentives and excise taxes. Tax Treaties and digital services taxation.

Issues related to corporate and international tax, including issues related to the taxation of manufacturing income and capital investment in the United States and Puerto Rico and issues related to the repatriation of intellectual property. Issues related to OECD negotiations on the taxation of global income.

Issues related to corporate and international tax, including issues related to rates, tax code section 951A, issues related to the taxation of manufacturing income and capital investment in the United States and Puerto Rico, and issues related to the repatriation of intellectual property (H.R. 7749). Issues related to the creditability of Puerto Rico excise taxes. Informational inquiry into the operation of the payroll tax deferral memorandum. Issues related to OECD negotiations on the taxation of global income.

Showing 8 of 20 unique descriptions from filings.